For everyone · 1 hr 27 min · Worth watching
Peptide risks, explained by a Stanford neurobiologist
Dr. Andrew Huberman — Professor of neurobiology and ophthalmology, Stanford School of Medicine; host, Huberman Lab
If you read one thing on this site and watch one video, make it this one. Eighty-seven minutes, a Stanford neurobiologist, and the word Risks in his own title — which already puts it ahead of most of what is published about peptides, including a fair amount published by people who sell them.
Why a supplier is sending you to a long video about the risks
Because the alternative is worse for everyone. The category's failure mode is a patient or a practice arriving with a molecule name they heard once and no framework for what it is, what it does, or what could go wrong. Nothing about that is good for us. A clinic that understands what it is ordering is a better customer for longer than one that does not.
He also spends real time on sourcing — where material comes from, and why that is the question underneath every other question. That is the argument this entire library makes, and it is more persuasive from someone with nothing to sell you.
What to watch for
- Every time he distinguishes what is established in humans from what is inferred from mechanism or animal work. He does it repeatedly and explicitly, and it is the single most transferable habit in the video.
- The sourcing section. If you take one practical thing away, take that one.
- Where he says the risk is not the molecule but the supply chain. That is a question you can put to any supplier, including us, and get a documented answer or a vague one.
